ENLIVEX THERAPEUTICS LTD (ENLV)

IL0011319527 - Common Stock

1.5  -0.1 (-6.25%)

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
26.18M25.80M19.29M9.79M8.62M
Research and Development
19.19M17.95M12.34M5.81M5.53M
Selling, General, and Administrative Expenses
6.99M7.10M6.41M3.70M2.90M
Operating Income
-26.18M-25.80M-19.29M-9.79M-8.62M
Interest Income/Expense
-4.53M-5.25M5.15M-2.03M-760.00K
Other Income/Expense
N/A-14.00K-328.00K-10.00K-10.00K
Income Before Taxes
-30.05M-31.06M-14.47M-11.82M-9.38M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-30.05M-31.06M-14.47M-11.82M-9.58M
EBITDA
-25.38M-25.02M-18.74M-9.50M-8.41M
 
Per Share Data
EPS Diluted Total Ops
-1.63-1.69-0.81-0.90-1.11
Non GAAP EPS
-1.63-1.69N/A-0.89N/A
 
Statistics

All data in USD

Charts